Literature DB >> 28220608

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.

Alexandra Reichel1, Henning Hamm1, Verena Wiegering2, Barbara Wiewrodt2, Henning Neubauer3, Karen Ernestus4, Beate Winkler2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28220608     DOI： 10.1111/ddg.12987

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  2 in total

1.  Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature.

Authors:  Matteo Chinello; Daniela Di Carlo; Francesca Olivieri; Rita Balter; Massimiliano De Bortoli; Virginia Vitale; Ada Zaccaron; Elisa Bonetti; Alice Parisi; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

2.  Initial dose recommendation for sirolimus in paediatric kaposiform haemangioendothelioma patients based on population pharmacokinetics and pharmacogenomics.

Authors:  Xiao Chen; Dong-Dong Wang; Hong Xu; Zhi-Ping Li
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.